Osaka-Based Sakai Chemical Industrial Expands Contract Pharmaceutical Production
This article was originally published in PharmAsia News
Executive Summary
Osaka-based drug maker Sakai Chemical Industrial will boost its Nagano, Osaka factory's capacity and operation rates with plans to expand its contract drug production business. Currently contracted by four pharmaceutical companies, Sakai produces 10 therapeutic and 25 over-the-counter drugs, with 1 million solid preparations and 100,000 liquid formulations per month. Sakai plans to increase the capacity to 2 million solids and 500,000 liquids and increase to 10 contract companies. The company also plans to be manufacture sprays, oral solutions and health foods. The company expects the income from the contract production business will increase to ¥1 billion from several hundred thousand yen. (Click here for more - Japanese language